Special Report – Veterans and HBOT
The unfortunate truth is that countless veterans, just like Simon, repeatedly battle suicidal thoughts. They struggle from their battle wounds and PTSD with each passing minute.
These brave souls protected our country, and it’s beyond time that we protect their future. Thankfully there is hope in HBOT.
Watch the 30 Minute Special Report
Veterans are at especially high risk for suicide due to the injuries they’ve endured and the horrific images they’ve seen. Post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI) rank high among the reasons why veterans are choosing death over living. But there is hope for new beginnings. Hyperbaric oxygen therapy (HBOT) is helping war veterans turn their lives around.
In this Special Report, Edward diGirolamo, host of the HBOT News Network, dives into HBOT and what the state of North Carolina is doing to help get veterans this life saving therapy. We hear from Melissa Spain, CEO of the Community Foundation of NC East, as she discusses their involvement to get NC Senate Bill 442 passed; a bill that has appropriated funds to provide HBOT to NC veterans who suffer from TBI and PTSD.
We are also greeted by Elena Schertz, Nurse Practitioner at Extivita-RTP in Durham, NC. Elena gives us a tour of their state-of-the-art clinic where soldiers are receiving HBOT. One of their veteran patients, Simon LeMay, agreed to share his story with us to help spread the hope that exists within the world of hyperbaric oxygen therapy.
Meet a true American Hero, Simon LeMay, retired Sergeant Major with 25-years in the US Marine Corps. LeMay was deployed to Iraq and Afghanistan five times during a ten year period. He lost his best friend in battle and witnessed horrific incidents of violence and injury among his Marine bothers. Although LeMay was blessed to avoid serious physical injury to himself, he did come home with an invisible wound of war.
IED exposures left him with a TBI and visions of war and death haunted him with PTSD. Simon turned to alcohol and pain pills to ease the emotional and physical pain, leading him down a dark tunnel of depression and suicidal thoughts that almost ended in demise.
After hearing about it from friends, his loving family talked him into trying hyperbaric oxygen therapy to help heal his brain injuries. LeMay received treatment at Extivita- RTP in Durham, NC and states after 20-30 treatments he started realizing that he was once again “starting to feel emotion,” with the sense of worthlessness disappearing and the suicidal ideation being no more.
“I started looking forward to the next day,” Simon exclaims.
Also included in this Special Report is a raw and personal interview with Cate, Simon’s wife. Today she is thrilled with Simon’s progress, even calling hyperbaric oxygen therapy “God sent.”
Subscribe Now, It’s Free!
Recent HBOT News
Targeting hypoxia to overcome radiation resistance in head & neck cancers: real challenge or clinical fairytale?
Abstract: Tumor hypoxia is a major cause for failure of therapy in patients with inoperable head and neck cancers. Various anti-hypoxic treatment strategies (e.g. hyperbaric oxygenation, hypoxic cell sensitizers) have been tested in clinical trials in head and neck...
Clinical Trial – Ondansetron vs Ondansetron Plus Dexamethasone for Relieving Intrathecal Morphine Side Effects After C-section
Background: Common adverse side effects related to the use of neuraxial opioids in the
obstetric population include nausea, vomiting, and pruritus. Serotonin (5-HT3) receptor
antagonists, in particular ondansetron, have been identified as possible antipruritic agents.
It was reported that dexamethasone plus ondansetron is more effective than ondansetron for
prevention of postoperative nausea and vomiting but no additional effect on treating
pruritus.
Objectives: The purpose of this study is to compare the effect of prophylactic ondansetron
versus ondansetron plus dexamethasone after cesarean section on pruritus and postoperative
nausea and vomiting (PONV).
Methods: A prospective randomized double blind study that will be conducted between June 2016
and June 2017. Patients will be randomly allocated into two groups. The first group will
receive 4 mg intravenous (IV) ondansetron while the other group will receive 4 mg IV
ondansetron plus 8 mg dexamethasone.
Mild Hyperbaric Oxygen Inhibits Growth-related Decrease in Muscle Oxidative Capacity of Rats with Metabolic Syndrome.
Abstract: We examined the effects of mild hyperbaric oxygen on the properties of the soleus muscle in rats with metabolic syndrome. Five-week-old metabolic syndrome (SHR/NDmcr-cp, cp/cp) rats were divided into normobaric (CP) and mild hyperbaric oxygen (CP-H) groups...


